Explore topic-wise InterviewSolutions in .

This section includes InterviewSolutions, each offering curated multiple-choice questions to sharpen your knowledge and support exam preparation. Choose a topic below to get started.

1.

Which of the following is a characteristic of a quaternary protein structure?(a) Formed by any single peptide chain in a whole protein molecule(b) Arrangement of polypeptide chains(c) Arrangement of different folding of the structure(d) Arrangement of the water molecules on the surfaceI have been asked this question during an online interview.I need to ask this question from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

The correct option is (a) Formed by any SINGLE peptide chain in a whole protein molecule

To EXPLAIN I would say: Many proteins consist of a single polypeptide chain, and are DEFINED as monomeric proteins. Others may consist of two or more polypeptide chains that may be structurally IDENTICAL or totally unrelated. The ARRANGEMENT of these polypeptide subunits is called the quaternary structure of the protein.

2.

What bonds stabilize the extracellular structure of proteins?(a) Hydrogen bond(b) Disulfide bonds(c) Hydrogen bonds(d) Ionic bondsThis question was addressed to me in an international level competition.I need to ask this question from Biopharmaceuticals in chapter Biopharmaceuticals of Drug Biotechnology

Answer»
3.

Intracellular protein tertiary structures mostly held together by ___________(a) Covalent forces(b) Disulfide bridges(c) Weak forces(d) Ionic bondsThe question was posed to me in an online interview.I'd like to ask this question from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»

Correct choice is (C) WEAK FORCES

Easiest explanation: Tertiary structure is formed by the folding and packing of super secondary structures. It gives a globular shape. Tertiary structures are stabilized by the bonds which are mostly formed between the R groups. Protein tertiary structures are mostly held by weak forces.

4.

Which of the following will be a characteristic of homotypic quaternary structure?(a) Formed by any single peptide chain in a whole protein molecule(b) Arrangement of polypeptide chains(c) Association between identical polypeptides(d) Association between subunits of different structureThe question was asked in a job interview.I need to ask this question from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»

Correct answer is (C) Association between identical polypeptides

Easiest explanation: The biological function of some molecules is determined by MULTIPLE POLYPEPTIDE chains. Two kinds of quaternary STRUCTURES: both are multi-subunit proteins. Homotypic which is an association between identical polypeptide chains. Heterotypic which will be interactions between subunits of very different structures.

5.

Adjacent polypeptide segments are stacked one above other.(a) True(b) FalseThe question was posed to me in my homework.I want to ask this question from Biopharmaceuticals in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Right answer is (B) False

The best explanation: Adjacent polypeptide segments are stacked together is a rule of Secondary structure of proteins. Secondary structure composition will be all alpha and BETA motifs together or segregated. Motifs are stable arrangements which MAKES a secondary structure stable. Packing side chains from adjacent secondary ELEMENTS PRODUCES a super secondary structure.

6.

B-Sheet is the most stable.(a) True(b) FalseI had been asked this question in a job interview.I would like to ask this question from Biopharmaceuticals topic in portion Biopharmaceuticals of Drug Biotechnology

Answer»

Correct OPTION is (a) True

To explain: There are some of the rules of Secondary protein structure and ONE of them is that the Beta SHEET is the most STABLE. The beta sheet is a paper like structure formed MOSTLY by the hydrogen bonds between the NH molecule and CO molecule of different amino acids.

7.

Alpha-helix and b-sheet, if occur together, are found in different structural layers.(a) True(b) FalseI had been asked this question in a job interview.I'd like to ask this question from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»

The correct option is (a) True

For explanation: There some of the rules of secondary STRUCTURE and these are hydrophobic SIDE groups must be buried inside the FOLDS, therefore, layers must be created (b-a-b; a-a). Alpha-helix and b-sheet, if occur TOGETHER, are found in different structural layers. Adjacent polypeptide segments are stacked together. The b-sheet is the most STABLE.

8.

What is the name of the bond formed when electrons are shared unequally?(a) Polar covalent bond(b) Nonpolar covalent bond(c) Hydrophobic interaction(d) Metallic bondThis question was posed to me during an interview.My question is taken from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

Correct choice is (a) POLAR covalent BOND

Explanation: A covalent bond is when a bond formed by the sharing of electrons. A nonpolar covalent n=bond is when electrons are shared EQUALLY such as H2 or Cl2. And Polar covalent BONDS are where the electrons are not shared equally such as H2O.

9.

What is the name of the bond formed when electrons are shared equally?(a) Disulfide bond(b) Nonpolar covalent bond(c) Hydrophobic interaction(d) Metallic bondI had been asked this question in semester exam.This is a very interesting question from Biopharmaceuticals in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

The correct choice is (B) Nonpolar covalent BOND

Explanation: When electrons between the atoms, while BONDING is shared equally, are known as non-polar covalent BONDS such as H2 or Cl2. And when the electrons are shared unequally they are called polar covalent bond such as H2O.

10.

What is the name of the bond found in metals; holds metal atoms together very strongly?(a) Disulfide bond(b) Ionic bond(c) Hydrophobic interaction(d) Metallic bondI got this question in an online quiz.Query is from Biopharmaceuticals topic in division Biopharmaceuticals of Drug Biotechnology

Answer»

The correct choice is (d) Metallic bond

To EXPLAIN I WOULD say: Metallic bonds are FOUND in metals. It arises from the ELECTROSTATIC ATTRACTION between electrons. When metals are bonded with proteins they are known as metalloproteins. They usually coordinate with nitrogen, oxygen, etc.

11.

What is the name of the bond formed between two ions by the transfer of electrons?(a) Disulfide bond(b) Ionic bond(c) Hydrophobic interaction(d) Covalent bondThis question was addressed to me in an internship interview.My enquiry is from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

Correct OPTION is (b) Ionic bond

The best I can explain: Bond FORMED between two ions by the TRANSFER of electrons. It involves electrostatic attraction between oppositely charged ions. In ionic bonds generally, a metal loses an electron becoming a POSITIVELY charged ION and a nonmetal accepts that ion becoming a negatively charged ion.

12.

What is the name of the bond formed between two ions by the sharing of electrons?(a) Disulfide bond(b) H bond(c) Hydrophobic interaction(d) Covalent bondThis question was posed to me during an online interview.Asked question is from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Correct option is (d) Covalent BOND

To elaborate: Covalent bond is the bond that occurs due to the SHARING of electrons between the molecules. This bond can form BONDS in any polyatomic ions or diatomic ions. This is ONE of the strongest bond and the energy required to break one such bond is 250 kJ/mol.

13.

Van der Waals forces are the only attractive forces present in nonpolar compounds.(a) True(b) FalseThis question was addressed to me in final exam.The origin of the question is Biopharmaceuticals topic in portion Biopharmaceuticals of Drug Biotechnology

Answer»

Right ANSWER is (a) True

Easy EXPLANATION: They are weak interactions CAUSED by momentary changes in electron density in a molecule. Thus they are the only force between non-polar molecules. Such as CH4 has no net dipole, at any one instant its electron density may not be completely SYMMETRICAL, RESULTING in a temporary dipole. This can induce a temporary dipole in another molecule. The weak interaction of these temporary dipoles constituents’ van der Waals forces.

14.

What is the name of the bond which is caused by changes in electron density?(a) Vander Waals force(b) H bond(c) Hydrophobic interaction(d) Electrostatic bondThe question was asked during an internship interview.Question is taken from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

The correct choice is (a) Vander WAALS force

To explain: Van der Waals forces are also known as London forces. They are weak interactions caused by MOMENTARY CHANGES in electron density in a molecule. They are the only attractive forces present in nonpolar COMPOUNDS. The surface area of a molecule determines the strength of the van der Waals interactions between MOLECULES.

15.

Which of the following is a characteristic of the secondary structure of a protein?(a) Amino acid sequence(b) Association of secondary structure(c) Alpha helix and beta sheets(d) Association of polypeptidesThe question was asked by my school teacher while I was bunking the class.This is a very interesting question from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»
16.

In secondary structure, the interactions of the R groups give a protein its specific three-dimensional tertiary structure.(a) True(b) FalseI got this question in an online interview.The above asked question is from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»

Right OPTION is (b) False

The best explanation: In the tertiary structure of a PROTEIN the interactions of the R groups give a protein its specific three-dimensional tertiary structure. GLOBAL but restricted to the amino acid polymer. Formed and stabilized by hydrogen BONDING, covalent (e.g. disulfide) bonding, hydrophobic PACKING toward the core and hydrophilic exposure to solvent.

17.

Which of the following of a protein molecule determines the strength of van der Waals force?(a) The molecular weight of the protein(b) PI of the protein(c) Number of amino acids present(d) The surface area of the moleculeThis question was addressed to me during an interview for a job.This interesting question is from Biopharmaceuticals topic in division Biopharmaceuticals of Drug Biotechnology

Answer»

The correct answer is (d) The surface area of the molecule

For explanation: The surface area of a molecule determines the strength of the VAN der WAALS interactions between molecules. The LARGER the surface area, the larger the attractive force between two molecules, and the STRONGER the intermolecular forces. They are weak interactions caused by MOMENTARY changes in electron density in a molecule.

18.

What is the name of the links between sulfur atoms of two cysteine amino acids?(a) Disulfide bond(b) H bond(c) Hydrophobic interaction(d) Electrostatic bondI had been asked this question in examination.Question is taken from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

Right option is (a) DISULFIDE bond

Explanation: Disulphide bonds are strong covalent links between the sulfur atoms of 2 CYSTEINE molecules. When two sulfur atoms from 2 different cysteine molecules FORM bind they release a WATER MOLECULE. It is an oxidative reaction.

19.

What is the approximate strength of the interaction between atoms in a covalent bond?(a) 500 kJ/mol(b) 150 kJ/mol(c) 100 kJ/mol(d) 250 kJ/molI had been asked this question in an interview for job.My enquiry is from Biopharmaceuticals topic in division Biopharmaceuticals of Drug Biotechnology

Answer» CORRECT choice is (d) 250 kJ/mol

Easiest explanation: Covalent BOND is a bond FORMED by the sharing of electrons. The bonds in all the polyatomic ions and diatomics are all covalent bonds. The energy needed to break a covalent bond is 250 kJ/mol. It is the strongest bond of ELECTROSTATIC, VAN der Waals force, and hydrogen bond.
20.

What is the name of attractions between polar or ionized R groups and water on the surface of the tertiary structure?(a) Disulfide bond(b) H bond(c) Hydrophilic interaction(d) Electrostatic bondThe question was asked in semester exam.My enquiry is from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

The correct choice is (c) Hydrophilic interaction

The explanation is: Hydrophilic attractions are attractions between polar or ionized R groups and the water on the SURFACE of the tertiary structure. Hydro means water and phallic means loving. These BONDS are water-loving bonds and THEREFORE ALWAYS takes into account the surrounding water.

21.

Which of the bonds are between the polar side groups of amino acids?(a) Disulfide bond(b) Hydrogen bond(c) Hydrophobic interaction(d) Electrostatic bondThis question was addressed to me during an online interview.The doubt is from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Right choice is (b) HYDROGEN bond

Best explanation: This BONDS in protein structure occurs between the COO group on one side of amino acid and polar side groups of other amino ACIDS. They are WEAK forces. Hydrogen bonds are responsible for the structural changes in the protein.

22.

Hydrophobic interactions are attractive interactions, resulting from the inability of water to form hydrogen bonds with certain side chains.(a) True(b) FalseI have been asked this question in a national level competition.I need to ask this question from Biopharmaceuticals in portion Biopharmaceuticals of Drug Biotechnology

Answer»

Correct ANSWER is (b) False

Easy explanation: Hydrophobic attractions are an attraction between the nonpolar alkyl groups and AROMATIC groups form a non-polar CENTER that is REPELLED by water. Hydrophilic attractions are an attraction between polar or ionized R groups and water on the surface of the tertiary structure.

23.

What is the strength of salt bridges?(a) 10-15 kcal/mol(b) 20-25 kcal/mol(c) 17-20 kcal/mol(d) 4-7 kcal/molI had been asked this question during an online interview.My doubt stems from Biopharmaceuticals in portion Biopharmaceuticals of Drug Biotechnology

Answer»

Correct answer is (d) 4-7 kcal/mol

Best explanation: The energy NEEDED to break a salt bridge is around 4-7 kcal/mol. Salt BRIDGES are electrostatic bonds between oppositely charged GROUPS. The ions on the R group of AMINO acids form salt bridges through electrostatic bonds.

24.

Salt bridges are which kind of bonds?(a) Disulfide bond(b) H bond(c) Hydrophobic interaction(d) Electrostatic bondThe question was posed to me in a national level competition.My doubt stems from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer» CORRECT ANSWER is (d) Electrostatic bond

Best explanation: Salt bridges are electrostatic bonds between oppositely charged GROUPS. The IONS on the R group of amino acids form salt bridges through electrostatic bonds. The STRENGTH of the bond is usually 4-7 kcal/mol.
25.

H bond doesn’t allow structural change.(a) True(b) FalseThe question was posed to me at a job interview.I want to ask this question from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Correct choice is (B) False

Explanation: Hydrogen bond is a very WEAK bond which is formed with the interaction between hydrogen and oxygen atoms. This although weak is a very important force for the STRUCTURE of a protein. This bond can EASILY BREAK and newly form by changing the structure of the protein.

26.

Which bond is weak and allow to be broken and reformed easily?(a) Disulfide bond(b) H bond(c) Hydrophobic interaction(d) Electrostatic bondI had been asked this question in quiz.This key question is from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»

Correct option is (B) H bond

Easy EXPLANATION: H bonds weak bonds ALLOWING to be broken and reformed easily. Allows STRUCTURAL change in the protein structure. Hydrogen bonds produce ‘functional’ molecules.

27.

What is the disulfide bond?(a) The ionic bond between S-S(b) Vander Waals interaction between two S atoms(c) The covalent bond between sulfur atoms on two cysteine amino acids(d) The covalent bond between any two sulfur atomsThe question was posed to me during an interview.The origin of the question is Biopharmaceuticals topic in portion Biopharmaceuticals of Drug Biotechnology

Answer»

Right answer is (c) The covalent bond between sulfur atoms on TWO cysteine amino acids

Best explanation: Covalent bond between sulfur atoms on two cysteine amino acids. Two cysteine amino acids atoms in close proximity will come together and then FORM a covalent bond in between with the release of a water molecule. The bond formed is covalent bond RATHER than IONIC, Vander WAALS or non-ionic.

28.

Interactions between atoms within the protein chain are one of the main forces that stabilize covalent structures in Proteins.(a) True(b) FalseThe question was asked in unit test.This intriguing question originated from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

The correct answer is (a) True

Easiest EXPLANATION: The main forces that stabilize the covalent structures of the protein are an interaction between atoms within the protein chain and interaction between the protein and the SOLVENT. Interactions which helps in stabilizing the protein STRUCTURE are disulfide bonds, HYDROGEN bonds, salt BRIDGES, hydrophobic interactions, hydrophilic interactions, and ionic interaction.

29.

One of the Main Forces that stabilize covalent structures in proteins is the interaction between the protein and the ____________(a) Other protein(b) Cells around(c) Solvent(d) Cell debris aroundThis question was addressed to me in my homework.Question is taken from Biopharmaceuticals topic in section Biopharmaceuticals of Drug Biotechnology

Answer»

Correct option is (c) Solvent

For explanation I would SAY: The interaction between the protein and the solvent around makes a protein structure stable. Also, the interaction between the protein atoms within the protein structure makes the structure stable. Most of the common interaction found in a protein structure are DISULFIDE bonds, HYDROGEN bonds, SALT bridges, hydrophobic interactions, HYDROPHILIC interactions, and ionic interaction.

30.

Salt Bridges is one of the Interactions stabilizing protein structure.(a) True(b) FalseI got this question at a job interview.This question is from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

The correct option is (a) True

To elaborate: Salt bridges are one of the SEVERAL types of interaction which helps in the stability of protein STRUCTURE. Salt bridges are IONIC INTERACTIONS between ionized R groups of the amino acids and the WATER on the surface of the tertiary structure.

31.

Which of the following is false for monolithic devices?(a) The drug used for these devices has large therapeutic indices(b) There are three categories of matrix devices(c) 1st type has the drug dissolved in the polymer matrix(d) 2nd type has drug dispersedThis question was addressed to me during an interview.My question comes from Biopharmaceuticals topic in portion Biopharmaceuticals of Drug Biotechnology

Answer»

Right answer is (b) There are three categories of matrix devices

To ELABORATE: The DRUG used in these devices has a large therapeutic index. Such that overdosing does not PRECIPITATE toxic reactions. There are two categories of matrix devices ONE is where the drug is dissolved in the polymer matrix and the other is where the drug is dispersed. The polymer employed for the matrix system MAY be hydrophilic or lipophilic. These polymers include PVC, PVP, and polysaccharides.

32.

Which of the following is true for monolithic devices?(a) These devices are used when the drug permeation rate is rapid(b) The release of the drug is controlled(c) Suitable for drugs with large therapeutic indices(d) The drug is contained in a powder form floating on liquidI have been asked this question in an internship interview.Enquiry is from Biopharmaceuticals in portion Biopharmaceuticals of Drug Biotechnology

Answer» RIGHT answer is (c) SUITABLE for drugs with large therapeutic indices

For explanation I would say: The DRUG used in these devices has a large therapeutic index. The drug release rate from the matrix is RAPID initially and then falls as the matrix gets depleted of the drug. The polymer employed for the matrix system may be hydrophilic or LIPOPHILIC. These polymers include PVC, PVP, and polysaccharides.
33.

Which of the following is false in regarding reservoir devices?(a) These devices are used when the drug permeation rate is rapid(b) The release of the drug is controlled(c) Suitable for low therapeutic indices(d) The drug is contained in a powder form floating on liquidI have been asked this question in a national level competition.Query is from Biopharmaceuticals topic in division Biopharmaceuticals of Drug Biotechnology

Answer»

Right answer is (d) The DRUG is contained in a powder form FLOATING on liquid

The explanation: The drug is contained in a reservoir as a suspension liquid or gel carrier. The thin POLYMERIC membrane is MADE up of olefinic polymers or PVC. When applied on skin it shows rapid release at first and then zero order release as long as the solution inside the reservoir is saturated.

34.

The absorption of the ophthalmic drug does not depend on which of the following?(a) Physicochemical properties of the permeating molecule(b) Drainage of tears(c) Output of tears(d) Size of the eyeballThe question was asked by my college director while I was bunking the class.My question comes from Biopharmaceuticals topic in division Biopharmaceuticals of Drug Biotechnology

Answer»

Correct answer is (d) Size of the eyeball

The BEST I can explain: The absorption of the OPHTHALMIC drug across the corneal membrane is a diffusion process and depends LARGELY on the physicochemical properties of the permeating molecule that is the drug. It also depends upon the drainage and output of tears. Drugs of ophthalmic USE are such as atropine, local ANESTHETICS, epinephrine, etc.

35.

What are the characteristics of the mixed monolithic-reservoir devices?(a) The drug has a large therapeutic index(b) Drug permeation rate is high(c) The drug-polymer matrix is layered by rate-controlling membrane(d) Administration of emulsionsI got this question by my college professor while I was bunking the class.The above asked question is from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Right answer is (c) The drug-polymer MATRIX is layered by rate-controlling membrane

The explanation: This device has drug RELEASE KINETICS INTERMEDIATE between monolithic and reservoir systems. Here the drug-polymer matrix is layered by a rate controlling membrane. The release is CONTROLLED initially by the membrane but as the drug gets depleted the rate is controlled by diffusion of the drug.

36.

What are the characteristics of the reservoir or membrane devices?(a) The drug has a large therapeutic index(b) Drug permeation rate is high(c) Control drug release by partitioning the drug from the oil(d) Administration of emulsionsI have been asked this question by my school teacher while I was bunking the class.This interesting question is from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

The correct option is (b) Drug permeation rate is high

Easiest explanation: These devices are used when the drug permeation through the stratum corneum is rapid than the rate of drug DIFFUSION from the device. It is suitable for drugs which have low therapeutic INDICES. When applied on SKIN it shows rapid release at first and then zero ORDER release as long as the solution inside the reservoir is SATURATED.

37.

The rate at which monolithic devices transfer drugs to the patient body is proportional to _______________ of time.(a) Square of time(b) The square root of time(c) Twice the time(d) Half the timeI got this question in an international level competition.I need to ask this question from Biopharmaceuticals topic in division Biopharmaceuticals of Drug Biotechnology

Answer»

Right OPTION is (b) The square root of time

For explanation: The drug RELEASE from the matrix system of the monolithic device is rapid INITIALLY and FALLS as the matrix gets depleted. The rate is thus proportional to the square root of time. The polymers EMPLOYED for matrix system may be hydrophilic or lipophilic.

38.

What are the characteristics of the monolithic devices?(a) The drug has a large therapeutic index(b) Aqueous solutions(c) Control drug release by partitioning the drug from the oil(d) Administration of emulsionsI got this question in semester exam.My enquiry is from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Right option is (a) The DRUG has a large therapeutic index

The explanation is: Monolithic devices are USED when the rate of drug diffusion from the device is higher than the rate of drug permeation through the STRATUM corneum. There are TWO categories of matrix devices one is where the drug is dissolved in the polymer matrix and the other is where the drug is dispersed.

39.

Which of the following characteristics is suitable for transdermal drug?(a) Large drug dose(b) Large molecular size(c) Drugs with narrow therapeutic indices(d) Drugs which are metabolized in the skinThe question was posed to me in final exam.This intriguing question originated from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

Correct option is (C) Drugs with NARROW therapeutic indices

The best I can explain: The transdermal route is unsuitable when the drug dose is large when the drug has a large molecular size, the drug is skin SENSITIZING and irritating. It ALSO becomes a problem when the drug is metabolized in the skin, the drug GOES protein binding in the skin, or even if the drug is highly lipophilic or hydrophilic.

40.

Which of the following drugs cannot be given as transdermal administration?(a) Drugs with very short half-lives(b) Drugs with narrow therapeutic indices(c) Easy removal and termination(d) Drugs against peptic ulcerI have been asked this question in homework.My doubt stems from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Right OPTION is (d) Drugs against peptic ulcer

The explanation is: Transdermal DELIVERY SYSTEMS are topically administered medications. Drugs with very short half-live example nitro-glycerine are administered as transdermal patches. Drugs with narrow THERAPEUTIC indices can be safely administered through transdermal patches. Problems for ORAL administration are not seen here.

41.

How are MLV liposomes made?(a) 2-10 bilayers of lipid(b) Series of concentric bilayers of lipid(c) The single bilayer of lipid(d) 100 bilayer of lipidI had been asked this question in an interview for job.This interesting question is from Biopharmaceuticals topic in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Right OPTION is (b) Series of concentric bilayers of lipid

For EXPLANATION I WOULD say: MLV are also KNOWN as multilamellar vesicles. These liposomes are made of series of concentric bilayers of lipids enclosing a small internal volume. 2-10 bilayers are lipid is used to make OLV. A SINGLE bilayer of lipid is used to make ULV.

42.

How are OLV liposomes made?(a) 2-10 bilayers of lipid(b) Series of concentric bilayers of lipid(c) A single bilayer of lipid(d) 100 bilayer of lipidThis question was addressed to me in class test.Query is from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer» CORRECT choice is (a) 2-10 bilayers of LIPID

The explanation: OLV is also known as oligolamellar VESICLES. These are made up of 2-10 bilayers of lipid surrounding a large internal volume which will be consisting of the drug. MLV is made up of a series of CONCENTRIC bilayers of lipids. ULV is made of a single layer of lipids. There can be varying sizes from 20-40 nm to 1000 nm.
43.

The drug loading in resealed erythrocytes can be done by 1st immersing the cells in a buffered hypertonic solution.(a) True(b) FalseI got this question in semester exam.Origin of the question is Biopharmaceuticals in chapter Biopharmaceuticals of Drug Biotechnology

Answer»

Right answer is (B) False

Best explanation: No the CELLS have to be immersed in a hypotonic SOLUTION. The cells must be immersed in a buffered hypotonic solution of drug which causes these cells to RUPTURE and release hemoglobin and trap the medication. The RESTORATION can be done by the restoration of the isotonicity and incubating them at 37°C, the cells reseal and are ready to use.

44.

Which of the following is a characteristic of battery powered pumps?(a) Free flowing powders(b) The system is programmed to release drugs at a controlled rate(c) Control drug release by partitioning the drug from the oil(d) Administration of emulsionsThe question was posed to me in an interview for job.This intriguing question originated from Biopharmaceuticals topic in division Biopharmaceuticals of Drug Biotechnology

Answer»

Correct answer is (b) The system is programmed to release drugs at a controlled rate

The best explanation: BATTERY powered PUMPS are such that they are programmed to release drugs of a certain AMOUNT when the RANGE of those components is differing from the normal value. Their design is such that the drug moves towards the exit and there is no BACKFLOW of the liquid. They are of two types these are peristaltic pump and solenoid driven reciprocating pump.

45.

After implantation of a vapour pressure pump, the body has to get heated by exercising so that the volatile liquid vaporizes.(a) True(b) FalseI had been asked this question during an online exam.I need to ask this question from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»

The correct choice is (b) False

To explain I WOULD say: After implantation, the VOLATILE liquid vaporizes at the body temperature and creates a vapor pressure that compresses and expels the drug through a series of flow regulators at a CONSTANT rate. Insulin and morphine have been successfully delivered by such implants. The disc-shaped device consists of two chambers. The infuscate chamber consists if the drug solution which will be separated by a freely movable flexible bellow from the vapor chamber CONTAINING vaporizable FLUIDS.

46.

Which of the following is a false statement for vapour pressure pump?(a) The device consists of two chambers(b) A chamber contains the drug solution(c) Drug solution chamber is separated by rigid walls(d) Vapour chamber contains vaporizable fluidsThe question was posed to me by my college professor while I was bunking the class.The doubt is from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer»

Correct answer is (c) Drug solution chamber is separated by rigid walls

For explanation I would say: The disc-shaped DEVICE consists of two chambers. The infuscate chamber consists if the drug solution which will be separated by a FREELY movable flexible bellow from the vapor chamber containing vaporizable fluids. The volatile liquid VAPORIZES at body temperature after IMPLANTATION thus creating vapour pressure which compresses and expels the drug through a series of flow regulators.

47.

Which of the following drugs are used in implants?(a) Pantoprazole(b) Mannitol(c) Amlodipine(d) Morphine antagonistThis question was posed to me in an international level competition.I'd like to ask this question from Biopharmaceuticals in section Biopharmaceuticals of Drug Biotechnology

Answer»

The correct CHOICE is (d) Morphine antagonist

To elaborate: Drugs which are generally used for such implants are steroids like contraceptives, morphine antagonists like naltrexone for opioid-dependent addicts. POLYMERS used for MAKING such implants are polymethacrylates, ELASTOMERS, etc. The system is generally prepared as implantable flexible or rigid rods or spherical tablets.

48.

Subcutaneous tissue is an ideal location for implants?(a) True(b) FalseI got this question in an international level competition.My question comes from Biopharmaceuticals topic in portion Biopharmaceuticals of Drug Biotechnology

Answer»

Right ANSWER is (a) True

The best explanation: Due to a very easy access for the implants the subcutaneous tissue became an ideal location for IMPLANTING. Moreover it has poor perfusion, slow drug absorption and less reactivity to many of the foreign materials. The system is generally prepared as implantable FLEXIBLE or RIGID rods or spherical tablets. Polymers used for making such implants are polymethacrylates, elastomers, ETC.

49.

Which is the disadvantage for implants?(a) More effective(b) More prolonged action(c) Significantly small dose(d) Need of microsurgeryI have been asked this question during an online interview.Question is taken from Biopharmaceuticals topic in portion Biopharmaceuticals of Drug Biotechnology

Answer»

The correct ANSWER is (d) Need of microsurgery

Explanation: The advantages of implants are these are more effective, have prolonged ACTION, and a small dose is sufficient for the patient. The major disadvantage of such systems is that microsurgery is REQUIRED for the implantation DEVICE. Although some implants can be implanted by SPECIALLY designed implant syringe.

50.

Which of the following should not be a property of implants?(a) Environmental stable(b) Biostable(c) Non-toxic(d) NonremovableThe question was posed to me in examination.Question is taken from Biopharmaceuticals in division Biopharmaceuticals of Drug Biotechnology

Answer» RIGHT option is (d) Nonremovable

Explanation: The IMPLANTS should be environment-friendly and should not breakdown under the influence of heat, light, air or moisture. It should be biostable, biocompatible, non-toxic and non-carcinogenic. It should be removable when REQUIRED. It should be able to RELEASE medication at a constant predetermined rate.